Lipocine

#药闻简讯# $Lipocine(LPCN)$ 完成 LPCN 1154 产后抑郁症（PPD）III 期临床试验的入组与给药
Q2 初公布主要数据

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-027914  Act: 34  Size: 244 KB 网页链接

$Lipocine(LPCN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002050709-25-000012  Act: 34  Size: 80 KB 网页链接

$Lipocine(LPCN)$ Squadron Capital Management, LLC及其关联方Squadron Master Fund LP、Matthew Sesterhenn和William Blank已提交了13G表格，详细说明了他们对Lipocine Inc.普通股的实际所有权情况。作为投资顾问，Squadron Capital Management, LLC可能被视为基金持有股份的实际所有人。Matthew...

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-024011  Act: 34  Size: 248 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-027273  Act: 34  Size: 2 MB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-002785  Act: 34  Size: 240 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-001254  Act: 34  Size: 258 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-001864  Act: 34  Size: 21 MB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-028597  Size: 5 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, item 5.02 Accession Number: 0001493152-25-027744  Act: 34  Size: 215 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-024012  Act: 34  Size: 27 MB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-028593  Size: 5 KB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-26-000361  Size: 5 KB 网页链接